Figures & data
Table 1 Descriptive statistics at the patient level or treatment period level
Figure 1 Survival times – discontinuation due to inefficacy by drug.
![Figure 1 Survival times – discontinuation due to inefficacy by drug.](/cms/asset/30c7928c-f64a-4e51-a172-db8ff2a44f89/dceo_a_124381_f0001_c.jpg)
Table 2 Cox regression – hazard ratios of discontinuation due to inefficacy, to adverse events, and to any reason
Figure 2 Cox-regression-predicted survival times – discontinuation due to any reason, by number of treatment, and TNF-α.
Abbreviations: sDMARD, synthetic disease-modifying antirheumatic drug; TNF-α, tumor necrosis factor-alpha.
![Figure 2 Cox-regression-predicted survival times – discontinuation due to any reason, by number of treatment, and TNF-α.](/cms/asset/4e3746ef-1c9d-4cfd-9eb9-d5854b7c4927/dceo_a_124381_f0002_c.jpg)